Simplex Trading »

Sab Biotherapeutics shares owned by Simplex Trading

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Simplex Trading

Quarter filed Position value Share count Share price at filing
2026-03-31 $18k 4.7k 3.83

More positions owned by Simplex Trading

State Str Spdr S&p 500 Etf T Put Put Option
State Str Spdr S&p 500 Etf T Call Call Option
Invesco Qqq Tr Put Put Option
Invesco Qqq Tr Call Call Option
Tesla Call Call Option
Ishares Tr Put Put Option
Nvidia Corporation Put Put Option
Nvidia Corporation Call Call Option
Ishares Tr Call Call Option
Tesla Put Put Option
Spdr Gold Tr Call Call Option
Meta Platforms Call Call Option
Apple Call Call Option
Alphabet Call Call Option
Spdr Gold Tr Put Put Option

View all positions for Simplex Trading

Top funds holding Sab Biotherapeutics

Vivo Capital
Caligan Partners
Perceptive Advisors
Commodore Capital
RA Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Millennium Management
Woodline Partners
Vanguard Capital Management
Sessa Capital IM
Boothbay Fund Management
Ameriprise Financial
Ensign Peak Advisors
Soleus Capital Management

View all funds holding Sab Biotherapeutics